Viewing StudyNCT02267109



Ignite Creation Date: 2024-05-06 @ 3:19 AM
Last Modification Date: 2024-10-26 @ 11:32 AM
Study NCT ID: NCT02267109
Status: COMPLETED
Last Update Posted: 2019-09-26
First Post: 2014-10-03

Brief Title: Phase 1 Trial of Ebola Vaccine in Mali
Sponsor: University of Maryland Baltimore
Organization: University of Maryland Baltimore

Organization Data

Organization: University of Maryland Baltimore
Class: OTHER
Study ID: HP-00061513
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of Maryland Baltimore
Lead Sponsor Class: OTHER
Responsible Party: Milagritos Tapia
Responsible Party Title: Assistant Professor Pediatrics Infectious Tropical Diseases
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: University of Maryland Baltimore
Old Name: None
Old Organization: None

Collaborators

Name Class
Leidos Biomedical Research Inc INDUSTRY
Wellcome Trust OTHER
National Institute of Allergy and Infectious Diseases NIAID NIH